MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma
Keiichiro Hattori; Mamiko Sakata‐Yanagimoto; Yasushi Okoshi; Yuki Goshima; Shintaro Yanagimoto; Rie Nakamoto‐Matsubara; Taiki Sato; Masayuki Noguchi; Shingo Takano; Eichi Ishikawa; Tetsuya Yamamoto; Akira Matsumura; Shigeru Chiba
Author Information: Department of Clinical and Experimental Haematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.